Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-31, Stock:JNJ, The news for the past five days is as follows:
2018-05-23: NEWS1: J&J hit with $21.7 million verdict in another talc asbestos cancer case.NEWS2: J&J Loses Second Talc-Asbestos Trial and Damages May Grow.NEWS3: Why Geron Corporation Stock Is Heating Up.NEWS4: Why Geron Corporation Stock Is Heating Up.NEWS5: Why Geron Corporation Stock Is Heating Up.NEWS6: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS7: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS8: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS9: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS10: Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis.NEWS11: Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis.NEWS12: Eli Lilly Gets FDA Approval for Taltz in Genital Psoriasis.NEWS13: Why the world needs more than one Ebola vaccine.NEWS14: Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?.NEWS15: Should PowerShares Dividend Achievers Portfolio (PFM) Be on Your Investing Radar?.NEWS16: Merck’s experimental and unlicensed Ebola vaccine is being used in latest outbreak.NEWS17: Is This Stock the Next Biotech Acquisition Target?.NEWS18: Is This Stock the Next Biotech Acquisition Target?.NEWS19: Is This Stock the Next Biotech Acquisition Target?.
2018-05-24: NEWS1: Jury recommends $25M in Johnson & Johnson lawsuit.NEWS2: Jury recommends $25M in Johnson & Johnson lawsuit.NEWS3: Novartis Gets Approval for Remicade Biosimilar in Europe.NEWS4: Novartis Gets Approval for Remicade Biosimilar in Europe.NEWS5: Jury awards $25M in Johnson & Johnson baby powder lawsuit.NEWS6: 5 Top Stock Trades for Friday Morning.NEWS7: 3 Pros, 3 Cons to Buying Medtronic PLC Stock.NEWS8: 3 Pros, 3 Cons to Buying Medtronic PLC Stock.NEWS9: J&J must pay $4 million in punitive damages in latest asbestos cancer trial.NEWS10: California Jury Delivers $25.75 Million Verdict in Asbestos Case Tying Johnson's Baby Powder to Mesothelioma.NEWS11: 3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More.NEWS12: 3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More.NEWS13: 3 Big Pharma Stocks with Huge Future Growth Potential.NEWS14: 3 Big Pharma Stocks with Huge Future Growth Potential.NEWS15: An ETF Play For Quality Stocks At A Fair Price.NEWS16: J&J Verdict Reaches Almost $26 Million in Baby Powder Trial.NEWS17: J&J Ordered to Pay $4 Million Punitive Award in Asbestos Suit.NEWS18: Vanguard Total Stock Market ETF Experiences Big Inflow.NEWS19: Vanguard Total Stock Market ETF Experiences Big Inflow.NEWS20: 3 Pros, 3 Cons to Buying Medtronic PLC Stock.NEWS21: Willams-Sonoma, Deutsche Bank and Johnson & Johnson are the Yahoo Finance charts of the day..NEWS22: 3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More.NEWS23: Biopharma M&A: You Ain't Seen Nothing Yet.NEWS24: 3 Big Pharma Stocks with Huge Future Growth Potential.NEWS25: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 25, 2018.NEWS26: Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 25, 2018.NEWS27: Stocks making the biggest moves premarket: BBY, MDT, HRL, MCK, DEO, FOXA, F, GM & more.NEWS28: Ex-Dividend Alert: Johnson & Johnson Boosted its Dividend by 7.1%; Will Trade Ex-Dividend on May 25, 2018.
2018-05-25: NEWS1: U.S. jury fails to reach verdict in latest J&J talc trial.NEWS2: U.S. jury fails to reach verdict in latest J&J talc trial over asbestos claims.NEWS3: No Verdict Reached in J&J Baby Powder Case.NEWS4: J&J Jury Fails to Reach Verdict in S.C. Cancer Suit Tied to Talc.NEWS5: A Focus on Eye Care Is Setting Up Johnson & Johnson Stock for the Future.NEWS6: A Focus on Eye Care Is Setting Up Johnson & Johnson Stock for the Future.NEWS7: 10 Top Health-Care Stocks That Never Break a Sweat.NEWS8: 10 Top Health-Care Stocks That Never Break a Sweat.NEWS9: 7 Dow Titans Rolling Over.NEWS10: 7 Dow Titans Rolling Over.NEWS11: A Focus on Eye Care Is Setting Up Johnson & Johnson Stock for the Future.NEWS12: AbbVie's Imbruvica's Phase III Study Meets Primary Endpoint.NEWS13: AbbVie's Imbruvica's Phase III Study Meets Primary Endpoint.NEWS14: Dow 30 Stock Roundup: GE's Transportation Unit to Merge With Wabtec, J&J & Glaxo's HIV Drug Gets EU Approval.NEWS15: Dow 30 Stock Roundup: GE's Transportation Unit to Merge With Wabtec, J&J & Glaxo's HIV Drug Gets EU Approval.NEWS16: One Click for the 500 Best High Yield Investments.NEWS17: One Click for the 500 Best High Yield Investments.NEWS18: 7 Dow Titans Rolling Over.NEWS19: Dow 30 Stock Roundup: GE&apos;s Transportation Unit to Merge With Wabtec, J&J & Glaxo&apos;s HIV Drug Gets EU Approval.NEWS20: 3 Likely Reasons Geron Stock Is Sizzling Hot Right Now.NEWS21: 3 Likely Reasons Geron Stock Is Sizzling Hot Right Now.NEWS22: AbbVie&apos;s Imbruvica&apos;s Phase III Study Meets Primary Endpoint.NEWS23: What Is Geron Corporation's Downside Risk?.NEWS24: What Is Geron Corporation's Downside Risk?.NEWS25: 3 Likely Reasons Geron Stock Is Sizzling Hot Right Now.NEWS26: What Is Geron Corporation&apos;s Downside Risk?.NEWS27: J&J Jury Asks Judge to Slap Cancer Warning on Baby Powder.NEWS28: 5 Top Stock Trades for Friday Morning.NEWS29: 5 Top Stock Trades for Friday Morning.
2018-05-29: NEWS1: Tuesday's Market Sell-Off: The 52 Week Highs and Lows.NEWS2: Johnson & Johnson Becomes Oversold.NEWS3: Johnson & Johnson Becomes Oversold.NEWS4: Johnson & Johnson (JNJ) Shares Cross 3% Yield Mark.NEWS5: Johnson & Johnson (JNJ) Shares Cross 3% Yield Mark.NEWS6: Notable Tuesday Option Activity: PCYG, CELG, JNJ.NEWS7: Notable Tuesday Option Activity: PCYG, CELG, JNJ.NEWS8: These 3 Stocks Shot Up 50% in 2017 -- Are They Still Buys?.NEWS9: These 3 Stocks Shot Up 50% in 2017 -- Are They Still Buys?.NEWS10: These 3 Stocks Shot Up 50% in 2017 -- Are They Still Buys?.NEWS11: Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference.NEWS12: 5 Clinical-Stage Biotech Stocks to Buy Under $10.NEWS13: Incyte’s Revenue Trend in Q1 2018.NEWS14: Stocks to Watch: Apple, Qualcomm, Disney, 21st Century Fox, Chevron, Johnson & Johnson, Starbucks.NEWS15: [$$] Juries Weigh Cases Over Alleged Harms of Johnson & Johnson Baby Powder.
2018-05-30: NEWS1: How Has JNJ’s Medical Devices Business Evolved in Recent Years?.NEWS2: How to Find a Growth Stock.NEWS3: How to Find a Growth Stock.NEWS4: 7 Inflation-Beating Stocks to Consider for This New Reality.NEWS5: JNJ’s Medical Devices Growth Plans amid Changing Market Dynamics.NEWS6: Johnson & Johnson: Focus on Entrepreneurial Organizational Model.NEWS7: Johnson & Johnson’s Strategy to Broaden Scope of Innovation Model.NEWS8: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 31, 2018.NEWS9: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 31, 2018.NEWS10: How Is Merck’s Hospital Acute Care Segment Positioned?.NEWS11: Johnson & Johnson in the Changing Consumer Market Landscape.NEWS12: Add Bucks County to list of those suing opioid manufacturers, distributors.NEWS13: Today’s Research Reports on Stocks to Watch: Axovant Sciences and Johnson & Johnson.NEWS14: Johnson & Johnson Hit 52-Week Low after Stopping Darzalex Trial.NEWS15: See what the IHS Markit Score report has to say about Johnson & Johnson..

Answer: Decrease